125 related articles for article (PubMed ID: 20945972)
1. Protective effects of clioquinol on human neuronal-like cells: a new formulation of clioquinol-loaded PLGA microspheres for Alzheimer's disease.
Barcia E; Salama A; Fernández-Carballido A; Negro S
J Drug Target; 2011 Sep; 19(8):637-46. PubMed ID: 20945972
[TBL] [Abstract][Full Text] [Related]
2. Clioquinol inhibits peroxide-mediated toxicity through up-regulation of phosphoinositol-3-kinase and inhibition of p53 activity.
Filiz G; Caragounis A; Bica L; Du T; Masters CL; Crouch PJ; White AR
Int J Biochem Cell Biol; 2008; 40(5):1030-42. PubMed ID: 18160328
[TBL] [Abstract][Full Text] [Related]
3. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
4. Controlled release of rasagiline mesylate promotes neuroprotection in a rotenone-induced advanced model of Parkinson's disease.
Fernández M; Barcia E; Fernández-Carballido A; Garcia L; Slowing K; Negro S
Int J Pharm; 2012 Nov; 438(1-2):266-78. PubMed ID: 22985602
[TBL] [Abstract][Full Text] [Related]
5. Poly(D,L lactic-co-glycolic acid) microspheres as biodegradable microcarriers for pluripotent stem cells.
Newman KD; McBurney MW
Biomaterials; 2004 Nov; 25(26):5763-71. PubMed ID: 15147822
[TBL] [Abstract][Full Text] [Related]
6. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.
Chaisri W; Ghassemi AH; Hennink WE; Okonogi S
Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499
[TBL] [Abstract][Full Text] [Related]
7. Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line.
Doggui S; Sahni JK; Arseneault M; Dao L; Ramassamy C
J Alzheimers Dis; 2012; 30(2):377-92. PubMed ID: 22426019
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
9. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
Bae SE; Son JS; Park K; Han DK
J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
[TBL] [Abstract][Full Text] [Related]
11. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable insulin-loaded PLGA microspheres fabricated by three different emulsification techniques: investigation for cartilage tissue engineering.
Andreas K; Zehbe R; Kazubek M; Grzeschik K; Sternberg N; Bäumler H; Schubert H; Sittinger M; Ringe J
Acta Biomater; 2011 Apr; 7(4):1485-95. PubMed ID: 21168535
[TBL] [Abstract][Full Text] [Related]
13. Retinal ganglion cells survival in a glaucoma model by GDNF/Vit E PLGA microspheres prepared according to a novel microencapsulation procedure.
Checa-Casalengua P; Jiang C; Bravo-Osuna I; Tucker BA; Molina-Martínez IT; Young MJ; Herrero-Vanrell R
J Control Release; 2011 Nov; 156(1):92-100. PubMed ID: 21704662
[TBL] [Abstract][Full Text] [Related]
14. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
Duvvuri S; Janoria KG; Mitra AK
J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of PLGA microspheres by the electrospraying method for delivering simvastatin for bone regeneration.
Nath SD; Son S; Sadiasa A; Min YK; Lee BT
Int J Pharm; 2013 Feb; 443(1-2):87-94. PubMed ID: 23291448
[TBL] [Abstract][Full Text] [Related]
16. In vitro study of GDNF release from biodegradable PLGA microspheres.
Aubert-Pouëssel A; Venier-Julienne MC; Clavreul A; Sergent M; Jollivet C; Montero-Menei CN; Garcion E; Bibby DC; Menei P; Benoit JP
J Control Release; 2004 Mar; 95(3):463-75. PubMed ID: 15023458
[TBL] [Abstract][Full Text] [Related]
17. Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.
Jaganathan KS; Singh P; Prabakaran D; Mishra V; Vyas SP
J Pharm Pharmacol; 2004 Oct; 56(10):1243-50. PubMed ID: 15482638
[TBL] [Abstract][Full Text] [Related]
18. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues.
Crotts G; Park TG
J Microencapsul; 1998; 15(6):699-713. PubMed ID: 9818948
[TBL] [Abstract][Full Text] [Related]
19. Preparation and immunological effectiveness of a Swine influenza DNA vaccine encapsulated in PLGA microspheres.
Zhao K; Li GX; Jin YY; Wei HX; Sun QS; Huang TT; Wang YF; Tong GZ
J Microencapsul; 2010; 27(2):178-86. PubMed ID: 20121488
[TBL] [Abstract][Full Text] [Related]
20. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
Ohashi K; Kabasawa T; Ozeki T; Okada H
J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
